{"classes":[{"categories":[{"measurements":[{"comment":"Upper bound of 95% CI not reached.","groupId":"OG000","lowerLimit":"44","upperLimit":"NA","value":"52"}]}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"64"}],"units":"Participants"}],"description":"The length of time from the start of treatment that diagnosed patients are still alive.","dispersionType":"95% Confidence Interval","groups":[{"description":"α DC1 vaccine\n\nand\n\nChemokine Modulatory Regimen:\n\nCelecoxib: Administered at 200 mg, once a day orally (T-TH) Rintatolimod: Intravenous infusion of 200 mg (Wed \\& and Fri, only) Interferon Alfa-2b: Intravenous infusion - 5 MU/m\\^2 or 20 MU/m\\^2 (T-Fri)","id":"OG000","title":"α DC1 Vaccine + Chemokine Modulatory Regimen"}],"paramType":"MEDIAN","populationDescription":"Patients treated with at least 1 course of α DC1 vaccine + 1 cycle of chemokine modulatory regimen who were evaluable for completing surgery.","reportingStatus":"POSTED","timeFrame":"Up to 5 years","title":"Overall Survival (OS)","type":"SECONDARY","unitOfMeasure":"months"}